Weekly Tech+Bio Highlights #58: Sanofi Licenses Neurosymbolic AI for Preclinical R&D

~$2.5B in Weekly Deal Value, Precision Oncology Flywheel, & Convergence of AI x CRISPR

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button: